Evaluating Pharmacists’ Readiness for Long-Acting Injectable HIV Prevention
Chapman University’s Dr. Jerika Lam and CSHP‘s CEO Dr. Loriann De Martini co-published “A mixed methods evaluation of pharmacists’ readiness to provide long-acting injectable HIV pre-exposure prophylaxis in California” in the Journal of Acquired Immune Deficiency Syndromes (JAIDS). The study investigated the underlying causes for why HIV prevention medication, pre-exposure prophylaxis (PrEP), isn’t widely used